Divestment of SBL Vaccin (SE) by the Swedish Government (SE) — SEK 345 million

Carnegie acted as adviser to the Swedish Government in the divestment of vaccine distributor SBL Vaccin to Active Biotech, a health care investment company. For SEK 145 million and a new share issue of SEK 200 million the divestment process was a limited controlled auction aimed at US and European trade buyers and investment groups. June, 1997.